These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10633535)

  • 1. DHEA treatment for HIV+ patients: effects on mood, androgenic and anabolic parameters.
    Rabkin JG; Ferrando SJ; Wagner GJ; Rabkin R
    Psychoneuroendocrinology; 2000 Jan; 25(1):53-68. PubMed ID: 10633535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial.
    Hunt PJ; Gurnell EM; Huppert FA; Richards C; Prevost AT; Wass JA; Herbert J; Chatterjee VK
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4650-6. PubMed ID: 11134123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placebo-controlled trial of dehydroepiandrosterone (DHEA) for treatment of nonmajor depression in patients with HIV/AIDS.
    Rabkin JG; McElhiney MC; Rabkin R; McGrath PJ; Ferrando SJ
    Am J Psychiatry; 2006 Jan; 163(1):59-66. PubMed ID: 16390890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of dehydroepiandrosterone administration on fatigue, well-being, and functioning in women with primary Sjögren syndrome: a randomised controlled trial.
    Hartkamp A; Geenen R; Godaert GL; Bootsma H; Kruize AA; Bijlsma JW; Derksen RH
    Ann Rheum Dis; 2008 Jan; 67(1):91-7. PubMed ID: 17545193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic and hormonal effects of oral DHEA in premenopausal women with HIV infection: a randomized, prospective, placebo-controlled pilot study.
    Poretsky L; Song L; Brillon DJ; Ferrando S; Chiu J; McElhiney M; Ferenczi A; Sison C; Haller I; Rabkin J
    Horm Metab Res; 2009 Mar; 41(3):244-9. PubMed ID: 18810712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of dehydroepiandrosterone (DHEA) supplementation on hormonal, metabolic and behavioral status in patients with hypoadrenalism.
    Libè R; Barbetta L; Dall'Asta C; Salvaggio F; Gala C; Beck-Peccoz P; Ambrosi B
    J Endocrinol Invest; 2004 Sep; 27(8):736-41. PubMed ID: 15636426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women.
    Morales AJ; Haubrich RH; Hwang JY; Asakura H; Yen SS
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):421-32. PubMed ID: 9876338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dehydroepiandrosterone on fatigue and well-being in women with quiescent systemic lupus erythematosus: a randomised controlled trial.
    Hartkamp A; Geenen R; Godaert GL; Bijl M; Bijlsma JW; Derksen RH
    Ann Rheum Dis; 2010 Jun; 69(6):1144-7. PubMed ID: 19854713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of dehydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters, and health-related quality of life.
    Barnhart KT; Freeman E; Grisso JA; Rader DJ; Sammel M; Kapoor S; Nestler JE
    J Clin Endocrinol Metab; 1999 Nov; 84(11):3896-902. PubMed ID: 10566625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between increased cortisol:DHEA ratio and malnutrition in HIV-positive men.
    Christeff N; Melchior JC; Mammes O; Gherbi N; Dalle MT; Nunez EA
    Nutrition; 1999; 15(7-8):534-9. PubMed ID: 10422082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a two-week physiological dehydroepiandrosterone substitution on cognitive performance and well-being in healthy elderly women and men.
    Wolf OT; Neumann O; Hellhammer DH; Geiben AC; Strasburger CJ; Dressendörfer RA; Pirke KM; Kirschbaum C
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2363-7. PubMed ID: 9215320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dehydroepiandrosterone substitution in female adrenal failure: no impact on endothelial function and cardiovascular parameters despite normalization of androgen status.
    Christiansen JJ; Andersen NH; Sørensen KE; Pedersen EM; Bennett P; Andersen M; Christiansen JS; Jørgensen JO; Gravholt CH
    Clin Endocrinol (Oxf); 2007 Mar; 66(3):426-33. PubMed ID: 17302879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind, placebo-controlled trial of testosterone therapy for HIV-positive men with hypogonadal symptoms.
    Rabkin JG; Wagner GJ; Rabkin R
    Arch Gen Psychiatry; 2000 Feb; 57(2):141-7; discussion 155-6. PubMed ID: 10665616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age.
    Morales AJ; Nolan JJ; Nelson JC; Yen SS
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1360-7. PubMed ID: 7515387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DHEA in elderly women and DHEA or testosterone in elderly men.
    Nair KS; Rizza RA; O'Brien P; Dhatariya K; Short KR; Nehra A; Vittone JL; Klee GG; Basu A; Basu R; Cobelli C; Toffolo G; Dalla Man C; Tindall DJ; Melton LJ; Smith GE; Khosla S; Jensen MD
    N Engl J Med; 2006 Oct; 355(16):1647-59. PubMed ID: 17050889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology.
    Labrie F; Bélanger A; Cusan L; Candas B
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2403-9. PubMed ID: 9253308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of dehydroepiandrosterone in the treatment of hypoactive sexual desire disorder: a report of gender differences.
    Bloch M; Meiboom H; Zaig I; Schreiber S; Abramov L
    Eur Neuropsychopharmacol; 2013 Aug; 23(8):910-8. PubMed ID: 23084789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term DHEA replacement in primary adrenal insufficiency: a randomized, controlled trial.
    Gurnell EM; Hunt PJ; Curran SE; Conway CL; Pullenayegum EM; Huppert FA; Compston JE; Herbert J; Chatterjee VK
    J Clin Endocrinol Metab; 2008 Feb; 93(2):400-9. PubMed ID: 18000094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DHEA treatment of Alzheimer's disease: a randomized, double-blind, placebo-controlled study.
    Wolkowitz OM; Kramer JH; Reus VI; Costa MM; Yaffe K; Walton P; Raskind M; Peskind E; Newhouse P; Sack D; De Souza E; Sadowsky C; Roberts E;
    Neurology; 2003 Apr; 60(7):1071-6. PubMed ID: 12682308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DHEA replacement in women with adrenal insufficiency--pharmacokinetics, bioconversion and clinical effects on well-being, sexuality and cognition.
    Arlt W; Callies F; Allolio B
    Endocr Res; 2000 Nov; 26(4):505-11. PubMed ID: 11196420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.